Tag: GPN Vaccines
South Australian-made pneumococcal vaccine to undergo human trials
GPN Vaccines, a South Australian biotech company, has successfully developed a new universal vaccine that targets a pneumonia-causing bacterium.Â
Developed in collaboration with the University...
SA biotech firm wins State Government grant to trial low-cost pneumococcal vaccine
South Australian biotech company GPN Vaccines has secured a $1 million State Government grant to complete its first-in-human clinical trials for a more effective and lower...
Featured Article
Modular switchgear built for faster, verified panel builds
As switchboard builders face tighter programmes and increasing scrutiny around compliance, the way enclosure, busbar and separation concepts work together has a direct impact on build time and verification effort.
